Citi

Here we have it: the largest deal of 2017. CVS Health Corp (NYSE: CVS) confirmed Monday its agreement to acquire Aetna Inc (NYSE: AET) as a standalone business unit for about $207 per share. The parties intend to close the deal in the second half of 2018 to yield $750 million in near-term synergies...

Cisco Systems, Inc. (NASDAQ: CSCO)'s fiscal first quarter earnings and outlook were strong enough to push the stock to a new multiyear high. Here's what some of Wall Street's top analysts are saying after the print: Barclays: The Positives And Negatives Barclays' Mark Moskowitz...

NVIDIA Corporation (NASDAQ: NVDA) can do no wrong in the eyes of the market, after its big Q3 earnings beat sent the stock higher by nearly 6 percent. But with Nvidia shares an incredible 1,000 percent in just three years, the debate rages on among analysts of just how much upside the stock has...

Shares of Sprint Corp (NYSE: S) lost more than 12 percent Monday morning and hit a new 52-week low of $5.72 after it was confirmed that ongoing merger talks with T-Mobile US Inc (NASDAQ: TMUS) ended with no agreement reached. Here's how some of Wall Street's notable analysts reacted:...

Shares of Twitter Inc (NYSE: TWTR) were trading lower by around 0.60 percent early Monday morning despite a notable upgrade from Wall Street. Citi's Mark May upgraded Twitter from Sell to Neutral with a $20 price target. Twitter has been lagging its internet peers year-to-date, up just 22...

Apple Inc. (NASDAQ: AAPL) stock jumped 2 percent on Friday to hit new all-time highs after the company reported a fiscal fourth-quarter earnings beat and issued guidance that impressed the market. A number of Wall Street analysts weighed in on Apple following the report. Here’s a rundown of...

Heading into its Wednesday earnings report, Facebook Inc (NASDAQ: FB) is decidedly well liked. The firm’s 42 Buy ratings are tempered by just two Sells and one Hold, according to TipRanks, which records an average price target of $191.33 with a range of $98 to $235. Recent trends back the...

Analysts at Citi turned bullish on Novavax, Inc. (NASDAQ: NVAX), a small-cap clinical-stage vaccine company. The firm's Joel Beatty upgrades Novavax's stock rating from Neutral to Buy with a price target boosted from $1.10 to $1.60. Novavax's phase 1 and phase 2 data for its flu vaccine called...

Shares of Macy's Inc (NYSE: M) lost more than 2 percent Monday and hit a new 52-week low of $19.00 after analysts at Citi turned bearish on the company. The firm's Paul Lejuez downgraded Macy's stock rating from Neural to Sell with a price target lowered from $21 to $16 (see his track record here...

Despite a more than 60-percent decline since the start of 2017, shares of J C Penney Company Inc (NYSE: JCP) could see a further decline of more than 50 percent, according to Citi analysts. The firm's Paul Lejuez downgraded JC Penney's stock rating from Neutral to Sell with a price target slashed...

Amazon.com, Inc. (NASDAQ: AMZN)'s stock spiked more than 12 percent Friday after the company reported third-quarter numbers that clearly impressed the market. A number of Wall Street analysts weighed in on Amazon following the report. Here’s a rundown of what they had to say. Voices...

Health care investors were blindsided on Thursday afternoon when Dow Jones reported that CVS Health Corp (NYSE: CVS) is exploring a $66 billion bid for Aetna Inc (NYSE: AET). As expected, Wall Street analysts have a lot to say about the potential deal. In a new note on Friday, Citigroup analyst...

Analysts at Citi no longer hold a bullish view on Biogen Inc (NASDAQ: BIIB). The firm's Robyn Karnauskas downgraded Biogen's stock rating from Buy to Neutral with a new $360 price target. A prior bullish stance on Biogen's stock has been in place since early February and was due to strong...

Advanced Micro Devices, Inc. (NASDAQ: AMD) has launched a series of new products in 2017 that have investors excited about the company’s future in a robust semiconductor market. However, Citi analyst Philip Lee isn’t so impressed by AMD’s new line of Ryzen CPUs and says Intel...

For traders looking for a good reason to buy Lululemon Athletica inc. (NASDAQ: LULU), Citi analyst Paul Lejuez just came up with 10. In a new note, Lejuez upgraded Lululemon stock from Neutral to Buy and gave a list of 10 reasons the stock is headed higher. Lejuez was impressed by Lululemon’s...